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Abstract
Background: Anti-neoplastic agents are widely used in the treatment of cancer and some non-neoplastic diseases.
These drugs have been proved to be carcinogens, teratogens, and mutagens. Concern exists regarding the possible
dangers of the staff handling anti-cancer drugs. The long-term exposure of nurses to anti-neoplastic drugs is still a
controversial issue. The purpose of this study was to monitor cellular toxicity parameters and gene expression in
nurses who work in chemotherapy wards and compare them to nurses who work in other wards.
Methods: To analyze the apoptosis-related genes overexpression and cytotoxicity effects, peripheral blood
lymphocytes obtained from oncology nurses and the control group.
The results: Significant alterations in four analyzed apoptosis-related genes were observed in oncology nurses. In
most individual samples being excavated, Bcl-2 overexpression is superior to that of Bax. Prominent P53 and Hif-1α
up-regulation were observed in oncology nurses. Moreover, all cytotoxicity parameters (cell viability, ROS formation,
MMP collapse, Lysosomal membrane damage, Lipid peroxidation, Caspase 3 activity and Apoptosis phenotype) in
exposed oncology nurses were significantly (p < 0.001) higher than those of unexposed control nurses. Up-
regulation of three analyzed apoptosis-related genes were observed in nurses occupationally exposed to anti-
cancer drugs.
Conclusion: Our data show that oxidative stress and mitochondrial toxicity induced by anti-neoplastic drugs lead
to overexpression of apoptosis-related genes in oncology nurses.
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Background
Chemotherapy is an important method for cancer treat-
ment that is used for anti-cancer drugs to cure patients.
Anti-neoplastic drugs are extremely active biological
compounds and their actions are non-selective [1]. Pre-
vious studies showed the possible dangers there to the
staff handling anti-cancer drugs [2, 3]. Mutagenic and
carcinogenic effects of anti-cancer drugs were shown in
1969 by the International Agency for Research on
Cancer [4, 5]. Mutagenesis, chromosomal damages, skin
hyperpigmentation, abortion, premature birth, and ab-
normal pregnancies are shown in that people who are in
contact with anti-neoplastic drugs [3]. Anticancer drugs
can also produce reactive oxygen species (ROS) which
purportedly leads to mutations and DNA damage. Over-
production of ROS can affect lipids, protein, and DNA
of the cell and lead to destroying the structure and func-
tion of cells [6]. At low doses, ROS had been associated
with induction of cell survival signaling pathways, whilst
at high doses activate death signaling through apoptosis
and necrosis [7]. Oxygen-free radicals activate the tumor
suppressor protein p53 at lower doses causes DNA re-
pair, cell cycle arrest, and senescence. Well, if damages
were very intense, p53 can control apoptosis transcrip-
tionally by up-regulating pro-apoptotic members such as
Bax, Bid, Puma, Noxa and Apaf-1, DR-4, FasL, Fas and
DR-5 and down-regulating pro-survival proteins such as
IAPs, Bcl-XL, Bcl-2 and surviving [8]. In the cytosol, P53
can translocate to mitochondria and interact straightly
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: j.pourahmadjaktaji@utoronto.ca
4Department of Pharmacology and Toxicology, School of Pharmacy, Ardabil
University of Medical Sciences, Ardabil, Iran
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shahid
Beheshti University of Medical Sciences, Tehran, Iran
Full list of author information is available at the end of the article
Ramazani et al. BMC Pharmacology and Toxicology           (2019) 20:74 
https://doi.org/10.1186/s40360-019-0372-0
with Mcl-1, Bcl-XL and Bcl-2 and the pro-apoptotic pro-
teins Bak and Bax, which lead to mitochondrial membrane
potential (MMP) collapse, the release of pro-apoptotic fac-
tors and apoptosis. Overexpression of the pro-apoptotic
proteins can lead to increased mitochondrial membrane
collapse and release of cytochrome c, which finally can
lead to ectopic apoptosis in lymphocytes [8, 9].
It is well known that oncology nurses are subject to
many antineoplastic drugs. Nurses are exposed to anti-
cancer drugs during preparation and administration. Ex-
posure to antineoplastic drugs can occur mainly to
hands and occasionally to other body parts or through
contact with patients treated with anti-cancer drugs via
their clothing and excreta [10, 11]. There several studies
about the evaluation of anti-cancer drug apoptosis in
lymphocytes of nurses [12–14]. Often these studies are
focused on identifying a new diagnostic marker for
nurses exposed to anti-cancer drugs in workplaces. We
recently studied mitochondrial and cytotoxicity parame-
ters in lymphocytes and isolated mitochondria of oncol-
ogy nurses. Our results showed that mitochondrial
toxicity and cytotoxicity parameters in the exposed
group were remarkably increased compared to the unex-
posed group. Also, genotoxic, cytotoxicity and apoptosis
monitoring in nurses handling cytotoxic drugs indicated
chromosomal abnormalities, oxidative stress and cell
death in the peripheral blood lymphocytes [15]. The
present study focused on the analysis of apoptosis-
related genes, for this purpose, we monitored cellular
toxicity parameters and gene expression in nurses who
work in chemotherapy wards and compare it to nurses
who work in other wards.
Methods
Sample collection
All nurses that work in chemotherapy wards of Shahid
Beheshti University hospitals were chosen by entering and
exit criteria by physician test. The minimum working time
in the chemotherapy ward was 6months and 45 h per
week. Demographic data such as age, sex, time exposure,
smoking status, and alcohol drinking were collected. The
sample size was determined based on the power and stand-
ard deviation of variables in previous studies by power and
sample size program software (50 nurses for each group).
Blood samples were collected (about 15 ml) in tubes
containing EDTA-K2 anticoagulant agent, nurses were
fasting. Control nurses who work in other wards of hos-
pitals were chosen by the same condition as exposure
nurses. All experiments were performed at Shahid
Beheshti University of Medical Sciences.
Isolation of lymphocytes
The nurse’s lymphocytes were isolated using the Ficoll
standard method. Diluted blood samples with normal
saline were layered on 3ml Ficoll-Paque PLUS, at 2500
rpm for 20 min and lymphocyte layer was centrifuged
and collected, the obtained cells were suspended in
erythrocyte lysis buffer (10 mM NaHCO3, 1 mM EDTA,
150 mM NH4Cl, pH 7.4), and incubated at 37 °C for 5
min. The PBS was immediately added, and the lympho-
cytes were centrifuged at 1500 g and 20 °C, for 10 min.
The supernatant was discarded, and the lymphocytes
were washed twice with RPMI1640. The lymphocytes
were resuspended in RPMI1640 medium with 10% FBS
and L-glutamine, using trypan blue exclusion dye were
counted. The cell viability was over 95% and lympho-
cytes were retained in a humidified atmosphere with 5%
CO2 at 37 °C. The cell concentration used in each test
was 10 × 106 cells/ml [15].
MTT assay
The viability assessment was measured by the MTT
method. The absorption of formazan dyes was read at
570 nm wavelength by an ELISA plate reader. All data
were confirmed by using replication for at least three
identical experiments [16].
Annexin V/Propidium iodide staining
Apoptosis and necrosis were determined by using the
apoptosis detection kit (K101 BioVision, CA, USA). In
summary, lymphocytes were resuspended in 500 μl bind-
ing buffer and then FITC-conjugated Annexin V and
propidium iodide (PI) were added and after 5-min incu-
bation, samples were monitored by flow cytometer (Bec-
ton–Dickinson, USA) [17].
Caspase 3 activity assay
Activation of caspase 3 was determined in lymphocytes
by Sigma’s caspase-3 assay kit (CASP-3-C). The hydroly-
sis of a substrate peptide, Ac-DEVD-PNA, by caspase-3
is the base of this colorimetric assay. The concentration
of p-nitroaniline (μM) released from the Ac-DEVD-PNA
is computed from absorbance values obtained at 405 nm
wavelength by an ELISA plate reader. Defined, p-
nitroaniline concentrations were used for the prepar-
ation of a calibration curve [17].
ROS detection
To measure the rate of lymphocytes ROS formation,
dichlorofluoresceindiacetate (DCFH-DA, 1.6 μM) was
added to the lymphocytes. The fluorescence intensity of
dichlorofluorescein (DCF) was detected at excitation and
emission wavelengths 490 nm and 525 nm, respectively
by using a fluorescence spectrophotometer [16].
Lipid peroxidation assessment
Lipid peroxidation detection in lymphocytes was per-
formed by measuring the amount of malondialdehyde
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(MDA) during the disintegration of lipid hydroperoxides
by monitoring the absorbance at 532 nm in a spectro-
photometer [16].
Lysosomal damage assay
Lysosomal damages in lymphocytes were measured by
acridine orange dye. Acridine orange that was remaining
in the cell suspension was measured at 495 nm excita-
tion and 530 nm emission wavelengths by a fluorescence
spectrophotometer [16].
MMP assay
Mitochondrial uptake of Rhodamine 123 dyes (1.5 μM), has
been applied for estimating MMP collapse. The amount of
Rhodamine 123 remaining in the incubation media was
measured at 470 nm excitation and 540 nm emission wave-
lengths by a fluorescence spectrophotometer [16].
RT-qPCR analysis
The expression of six genes (Bcl-2, Bax, P53, TopIIa,
TopIIb, and Hif-1a) was determined using RT-qPCR,
primer sequences for genes shown in Table 1. Total
RNA was extracted from lymphocyte samples using the
RNeasy mini kit (including RNase free DNaseI) (Qiagen,
Germany). Using electrophoresis in 1.2 agarose gel all
extracts were qualitatively evaluated and spectrophoto-
metrically quantitated (Ultrospec 1100, Amersham Phar-
macia Biotech). 1 μg of total RNA was exposed to cDNA
synthesis. First-strand cDNA was produced using the
RevertAid Reverse Transcriptase kit (Yekta Tajhiz Co.,
Iran). Primers for amplification of these genes were
listed in Table 1. The real-time quantitative RT-PCR
analysis and amplification of cDNA were performed
using a Rotor-Gene 6000 thermocycler (Corbett Re-
search, Australia) using an SYBR Green kit (Yekta Tajhiz
Co., Iran). The thermal condition was as follows: Pre-
denaturation at 95 °C for 5 min, denaturation at 95 °C
for 10 s, annealing at 60 °C for 20 s, extension at 70 °C
for 20 s, 40 cycles in total. β-actin was used as a house-
keeping gene to normalize the cDNA variation. Relative
quantification was made using the Pffafl method (16).
Each experiment was repeated three times [18].
Statistical analysis
The unpaired T- test was used to compare the results
between two nurses’ groups using GraphPad Prism 7
software, with P < 0.05 being significant. For RT-qPCR,
relative quantification was made using the Pffafl method
and another analysis was performed by the Two-way
ANOVA test and Bonferroni post-test. Based on pffafle
analysis, a ratio above 2 is considered as Overexpression
and below 0.5 as Low Expression.
Results
Demographic data
Important demographic data were shown in Table 2.
83.33% of nurses were women and 16.67% were men in
both groups. The average age of oncology nurses was
29.27 years and in the control group were 28.69 years.
Control nurses never work in the oncology ward and an
average of times of exposure to oncology nurses was
27.43 months. A series of general clinical symptoms, in-
cluding a headache, eye irritation, skin irritation, dizzi-
ness, dyspnea, chest pain, sleep problems, and nausea
were evaluated in nurses in both control and exposed
groups. All of the above-mentioned symptoms were
higher in nurses in the exposed group, but most of these
nurses complained of skin irritation, dizziness, a head-
ache, and heavy headache (Fig. 1).
Viability assessment
According to Fig. 2, the lymphocyte viability of oncology
nurses was significantly lower than those of control
nurses (p < 0.001).
Apoptosis assay
Using cell flow cytometry and AnnexinV-PI staining, cell
status was determined for apoptosis and necrosis in con-
trol and exposed groups. According to the data, lympho-
cytes which were at apoptosis state in chemotherapy
nurses were more than in control nurses (P < 0.001)
which are shown in Fig. 3. Quadrant 1 includes necrosis
cells (Annexin V−/PI+), Quadrant 2 includes cells under
secondary necrosis or late apoptosis (Annexin V+/PI+),
Quadrant 3 includes live cells (Annexin V−/PI-) and
Quadrant 4 includes cells under early apoptosis
(Annexin V+/PI-).
Table 1 Primer sequences for six genes which chosen for gene
expression analysis
Gene Size of base pairs Sequence of primer 5′ 3′
Bax 155 F: CCCGAGAGGTCTTTTTCCGAG
R: CCAGCCCATGATGGTTCTGAT
Bcl-2 89 F: GGTGGGGTCATGTGTGTGTGG
R: CGGTTCAGGTACTCAGTCATCC
P53 181 F: GTCTGGGCTTCTTGCATT
R: GTCATGTGCTGTGACTGC
ACTB 138 F: AACGGTGAAGGTGACAGCAGTCG
R: GGCAAGGGACTTCCTGTAACAACG
Hif-1a 164 F: ACAGCCTCAGGAAACAGAGCAGG
R: CGCTTTCTCTGAGCATTTGCAAAGC
TopoIIa 175 F: GAATCAGATAGGAGCAGTGACG
R: GTGGACTAGCATCTGATGGGAC
TopoIIb 182 F: GCACTGACCTGGGTGAACAA
R: ACCCACATGAACTGCGTCAA
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Activation of Caspase 3
The activity of caspase 3 in cytoplasm starts a process
that leads to apoptosis in cells. This activation was mea-
sured by a substrate of caspase 3. Figure 4a shows that
the activity of caspase 3 in lymphocytes isolated from
oncology nurses has been signed (p < 0.001) higher than
that of control nurses.
Measurement of ROS formation
Disruption of the balance between cellular ROS formation
and endogenous antioxidants can start oxidative stress in
cells. Our results show that the amounts of ROS formation
in lymphocytes of oncology nurses were significantly (p <
0.001) higher than those of control nurses (Fig. 4b).
Lipid peroxidation in isolated lymphocytes
Lipid peroxidation was determined by measuring the
amount of malondialdehyde (MDA) in isolated lympho-
cytes. As shown in Fig. 4c, lymphocytes of oncology
nurses have significantly (p < 0.001) higher than MDA
compared to those of control nurses.
Lysosomal membrane integrity.
Lysosomal integrity was determined by Acridine Orange
fluorescent dye redistribution in lymphocytes isolated
Table 2 The demographic characteristics of study nurses
Control nurses Oncology nurses
Male 16.67% 16.67%
Female 83.33% 83.33%
Smoking 0 0
Alcohol drinking 0 0
Average of age (year) 28.69 ± 4.008 29.27 ± 3.693
Average time of work in oncology ward (month) 0 25.43 ± 27.73
Antioxidant therapy intake > 1% > 1%
Use of personal protection tools 99% 99%
Interference in preparation drug stage 100% 0
Pregnance nurses (number) 0 2 *
*pregnancy nurses removed from this study
Fig. 1 The number of symptoms observed in exposed and unexposed nurses to antineoplastic drugs. Two groups analyzed by the chi-square
test. All of the above-mentioned symptoms were obviously higher in nurses in the exposed group compared to the unexposed group
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from the nurse’s blood. The results of the lysosomal integ-
rity test show that nurses who work in the oncology ward
have higher lysosomal membrane damage compared to
those of control nurses (Fig. 5a) (p < 0.001).
Mitochondrial membrane potential collapse
To understand changes in mitochondrial membrane po-
tential, we used Rhodamine 123 dye. When the fluores-
cence intensity related to Rhodamine 123 release from
mitochondria into the cytosol, is high, it means that the
loss of mitochondrial membrane potential is also high.
Our results showed that lymphocytes of oncology nurses
demonstrate more decline in mitochondrial membrane
potential rather than those of control nurses (Fig. 5b)
(p < 0.001).
Determination of Bax, Bcl-2, P53, Hif-1a, topoisomerase-
IIa and topoisomerase-IIb level
Relative expression levels of six genes with central roles
in the regulation of apoptosis, chromosome segregation,
transcription, DNA repair, and glucose metabolism were
analyzed by RT-qPCR in two groups of nurses (oncology
and controls). Data analysis of 50 exposed nurses dem-
onstrated reduced Bcl-2 expression (significantly re-
duced expression value, less than 0.5) in 20 cases (40%)
and increased Bcl-2 expression in 15 cases (30%) (not
significantly overexpression, a value less than 2) and
Fig. 2 The viability of lymphocytes isolated in exposed and control nurses, cell viability were significantly higher in nurses in the exposed group
compared to the unexposed group. Values (mean ± SD) are from three independent experiments (n = 3). ***p < 0. 001. Results are expressed as
means ± SD, n = 50
Fig. 3 Apoptosis assay in exposed and unexposed nurses. a Unexposed nurses; (b) exposed nurses. Apoptosis was measured by the annexin V
assay using flow cytometry. The assay gives information about the number of live cells (AV−/PI-), apoptosis cells (AV+/PI-), necrotic cells (AV−/PI+)
and secondary necrosis cells (AV+/PI+)
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approximately equal expression of Bcl-2 (normal expres-
sion) in 15 remaining cases (30%). The expression of this
gene was nearly the same in cases in the control group.
A comparison of the average expression of Bcl-2 in two
groups did not show a significant difference between
them (p > 0.05). Whereas the expression of Bax in-
creased significantly (P < 0.05) in 20 cases (40%) and the
remaining was nearly the same in the rest of exposed
nurses. Cases in the control group showed normal simi-
lar expression. A comparison of the average expression
of Bax in two groups did not show a significant differ-
ence between them (p > 0.05). The real-time PCR data
demonstrated increased expression of Bax: Bcl-2 ratio of
40% of exposed nurses as compared with control ones.
The average expression of Bax: Bcl-2 ratio of exposed
nurses was significantly different from that in the control
group (P < 0.05). P53 was overexpressed in 20 cases
(40%) in the exposed group. The average expression of
P53 in exposed nurses was significantly different from
that in the control group. It is expected that the expres-
sion of wild type Top2α and Top2β decreases in chemo-
therapeutic resistant tumor cells. However, these two
genes expressed similarly in two groups. The average ex-
pression of both genes in exposed nurses was not signifi-
cantly different from that in the control group. It was
shown that Hif-1α overexpresses in chemotherapeutic
resistant tumor cells, especially in acute lymphoblastic
leukemia (ALL) and acute myeloid leukemia (AML).
Whereas Hif-1α neither overexpressed nor showed a sig-
nificant difference in two groups (Fig. 6).
Fig. 4 Caspase-3 activity (a). ROS formation was measured (b). Malondialdehyde amounts formed during the decomposition of lipid
hydroperoxides (c). All of them was significantly higher in nurses in the exposed group compared to the unexposed group. ***p < 0.001 ****p < 0.
0001. Results are expressed as means ± SD
Fig 5 Lysosomal membrane damage (a). MMP collapse. b. Two parameters were significantly higher in nurses in the exposed group compared to
the unexposed group Each bar represents mean ± SD (n = 50). **** p < 0.0001 significant differences compared to the unexposed group
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Discussion
We previously reported the results of mitochondrial tox-
icity and oxidative stress parameters in nurses that have
been occupationally exposed to antineoplastic drugs
[15]. In the current study, we searched apoptosis and ex-
pression of apoptosis-related genes in the same set of
the antineoplastic drug-exposed nurses. According to
biochemical observations, the obtained results in our
study showed that the mitochondrial toxicity and oxida-
tive stress parameters in the lymphocytes of nurses in
the oncology ward are higher than significantly com-
pared with other nurses. We confirmed that apoptosis in
antineoplastic drug-exposed nurses was higher than un-
exposed nurses with antineoplastic drugs (Fig. 3).
Bcl-2 family proteins have a key role in the regulation
of cell death [19]. There two types of proteins in this
family, including the pro-survival subfamily like Bcl-2
band the pro-apoptotic subfamily such as Bax [20]. Anti-
apoptotic Bcl-2 family members support the viability of
cells by binding to multidomain pro-apoptotic members
and inhibiting apoptotic activities of them. However,
multidomain pro-apoptotic Bcl-2 family members attack
the mitochondria and lead to mitochondrial outer mem-
brane permeability and apoptosis [21]. In this study, we
showed that exposed nurses with antineoplastic drugs
have higher pro-apoptotic Bcl-2 proteins than unex-
posed nurses (Fig. 6). These data are correlated with the
induction of apoptosis, cytotoxicity and mitochondrial
membrane potential collapse. Cellular ROS formation
can be reduced by Bcl-2. Antioxidant effects of Bcl-2 are
shown by previously published studies. These studies
suggested that the pro-survival Bcl-2 family decrease
glutathione depletion in cells [22, 23]. We observed a
higher level of ROS formation in the exposed nurses
compared with unexposed nurses. The obtained results
suggested that a decrease in pro-survival Bcl-2 is effect-
ively in ROS content in exposed nurses. Deactivation of
the anti-apoptotic Bcl-2 family members leads to activa-
tion of the pro-apoptotic Bcl-2 such as Bak and Bax,
these occurrences are thought to happen in parallel, fi-
nally resulting in cytochrome c release through MMP
collapse, activation of caspases and apoptosis [21, 24].
Our results showed that an increase in Bax/Bcl-2 is ac-
companied by an MMP collapse in mitochondria, activa-
tion of caspase 3 and apoptosis in exposed nurses
(Figs. 3, 4A and 5B).
Hif-1α is remarked as the master transcriptional con-
troller of development and cellular reply to hypoxia. The
overexpression and dysregulation of Hif-1α by genetic
alternations or hypoxia have been involved in the biol-
ogy of cancer, specifically in areas of energy metabolism,
angiogenesis and vascularization, tumor invasion and
cell survival [25]. A recent study showed that Hif-1α is
recruited to mitochondria in answer to oxidative stress
and safeguards against oxidative stress-induced apop-
tosis. In mitochondria, Hif-1α decreases ROS levels and
Fig 6 The relative expression of Bcl-2, Bax, P53, Top2α, Top2β, and Hif-1a (a) and relative expression of Bcl-2, Bax and Bax/Bcl-2 ratio (b) *
indicated the significant difference (p < 0.01) between exposed with unexposed nurses. Results are expressed as means ± SD (n = 50)
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reverses mitochondrial damage [26]. Also, previous stud-
ies showed that HIF-1α decreases ROS formation via
multiple pathways and reverses mitochondrial damage
[27]. Our results here suggest that probably overexpres-
sion of Hif-1α in exposed nurses is for inhibition of
mitochondrial and oxidative damage induced by expos-
ing antineoplastic drugs.
Tumor suppressor P53 is a transcription factor that con-
trols cell growth [28]. New investigations showed that P53
can lead to changing from normal to an abnormal condi-
tion under different stress conditions in mitochondria.
When stress stimuli occur, like exposure to antineoplastic
in our study, ROS promote P53 to repair dysfunctional
mitochondria to finish mitochondrial degradation [29]. If
damage or stress is irreversible, P53 will translocate to
mitochondria, leading into necrosis or apoptosis [30].
Topoisomerase II is a type II DNA topoisomerase that
has been reported to be expressed in all mammalian
cells, but is widely expressed in cells that are differentiat-
ing for achieving post-mathisophytic status. Topoisom-
erase II plays an important role in various biological
areas such as transcription, DNA repair, neurodegenera-
tion, aging, HIV infection and cancer [31–35]. Exposure
to anti-cancer drugs, especially those targeting DNA
topoisomerases may change the expression pattern of
Top2α and Top2β genes [36]. We did not find a signifi-
cant difference in expression of these genes in two
groups (P > 0.05) and both groups showed normal ex-
pression. Additionally, exposure to these drugs may
cause resistance against them. Hif-1α can be used as a
biomarker that shows resistance as its expression en-
hances in resistant cells [37]. Neither of the groups
showed overexpression of this gene and a significant dif-
ference in the level of expression (P < 0.05).
We couldn’t detect all chemotherapy drugs concentra-
tion in the blood of nurses because the number of drugs
that are in use in chemotherapy wards of our country
Iran are more than 40 different drugs and measurement
of their exact concentration in the blood sample is not
possible at the same time. Besides, these drugs have syn-
ergistic and antagonistic effects on each other. There-
fore, the presence or absence of a single drug in blood at
the time of measurement is not a reason for the absence
or present of adverse effects.
Conclusions
In summary, the results of the current study showed that
oxidative stress and mitochondrial toxicity induced by
antineoplastic drugs lead to overexpression of apoptosis-
related genes in human lymphocytes.
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